U.S. market Closed. Opens in 15 hours 49 minutes

OVID | Ovid Therapeutics Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Revenue391.69K1.50M208.38M12.62MN/AN/AN/AN/AN/A
Cost of Revenue1.60M1.38MN/AN/A255.00KN/AN/AN/AN/A
Gross Profit-1.20M121.14K208.38M12.62M-255.00KN/AN/AN/AN/A
Operating Expenses58.08M57.05M84.17M94.05M61.41M52.93M65.01MN/AN/A
Selling, General & Admin29.91M32.43M37.23M30.63M19.25M19.14M15.04M12.95M6.58M
Research & Development28.17M24.62M46.94M63.42M42.16M33.79M49.97M9.59M6.61M
Other Operating Expenses1.001.38M-45.69K395.40KN/AN/AN/AN/AN/A
Operating Income-59.28M-55.55M124.21M-81.43M-61.41M-52.93M-65.01M-22.54M-13.19M
Other Expenses / Income6.94M1.38M-45.69K395.40K948.22K951.73K201.51K120.82K30.28K
Before Tax Income-52.34M-54.17M124.16M-81.04M-60.46M-51.98M-64.81M-22.41M-13.16M
Income Tax Expenses5.00-2.76M1.33M-306.85K-1.20M951.73KN/AN/AN/A
Net Income-52.34M-51.41M122.83M-80.73M-59.26M-51.98M-64.81M-22.41M-13.16M
Interest ExpensesN/A-2.76MN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding70.58M70.42M67.48M58.45M39.22M24.63M19.34M19.60M19.60M
Diluted Shares Outstanding70.58M70.42M68.07M58.45M39.22M24.63M19.34M19.60M19.60M
EBITDA-57.68M-55.55M124.45M-81.43M-61.41M-52.93M-64.73M-22.48M-13.18M
EBITDA Margin-14,726.99%-3,696.44%59.72%-645.40%0.00%0.00%0.00%0.00%0.00%
EBIT-52.34M-56.93M124.16M-81.04M-60.46M-51.03M-64.81M-22.41M-13.16M
EBIT Margin-13,362.17%-3,788.38%59.58%-642.26%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙